ListarEditados por otras instituciones por tema "P2Y12 inhibitor"

Mostrando ítems 1-1 de 1

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial.

Windecker, Stephan; Lopes, Renato D.; Massaro, Tyler; Jones-Burton, Charlotte; Granger, Christopher B.; Aronson, Ronald; Heizer, Gretchen; Goodman, Shaun G.; Darius, Harald; Jones, W. Schuyler; Aschermann, Michael; Brieger, David; Cura, Fernando; Engstrom, Thomas; Fridrich, Viliam; Halvorsen, Sigrun; Huber, Kurt; Kang, Hyun-Jae; Leiva-Pons, Jose L.; Lewis, Basil S.; Málaga Rodríguez, Germán Javier; Meneveau, Nicolas; Merkely, Bela; Milicic, Davor; Morais, Joao; Potpara, Tatjana S.; Raev, Dimitar; Sabate, Manel; de Waha-Thiele, Suzanne; Welsh, Robert C.; Xavier, Denis; Mehran, Roxana; Alexander, John H. (Wolters Kluwer Health, 2019)

Background: The safety and efficacy of antithrombotic regimens may differ between patients with atrial fibrillation (AF) who have acute coronary syndromes (ACS), treated medically or with percutaneous coronary intervention ...

Buscar en el Repositorio